581 results match your criteria: "Kanagawa Cardiovascular and Respiratory Center.[Affiliation]"

Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic interstitial pneumonia, which is characterised by progressive worsening of dyspnoea and lung function. Nintedanib treatment is recommended to slow IPF disease progression. The aim of this post-marketing surveillance (PMS) study was to evaluate the safety and effectiveness of nintedanib over 24 months in patients with IPF in a real-world setting in Japan.

View Article and Find Full Text PDF

: This study investigated the relationship between LA (LA) enhancement on three-dimensional (3D) late gadolinium enhancement (LGE) MRI and recurrence after catheter ablation in patients with AF (AF). : A total of one hundred patients with AF (mean age: 68 ± 9 years, 50% with paroxysmal AF) were included in this study. Each patient underwent a high-resolution 3D LGE MRI prior to catheter ablation, allowing for detailed imaging of the LA wall.

View Article and Find Full Text PDF
Article Synopsis
  • - A study investigated the effects of polymyxin B-immobilized fiber column (PMX) treatment on patients with acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF), who typically have a poor prognosis.
  • - Results showed a survival rate of 65% at day 28 after PMX treatment, which is significantly higher than the usual 40% survival rate seen with conventional treatments.
  • - The study concluded that PMX treatment is safe and potentially improves oxygenation and overall prognosis for AE-IPF patients.
View Article and Find Full Text PDF

Effects of immunosuppressants in patients with mild fibrotic hypersensitivity pneumonitis.

Respir Investig

November 2024

Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomioka-higashi, Kanazawa-ku, Yokohama, 236-0051, Japan.

Article Synopsis
  • The study investigates the effectiveness of immunosuppressants in patients with fibrotic hypersensitivity pneumonitis (HP), comparing those treated with prednisolone alongside immunosuppressants to those only receiving prednisolone without prior immunosuppressant treatment.
  • A total of 42 patients were analyzed, revealing that the group receiving immunosuppressants showed a significant decline in forced vital capacity (FVC) before treatment, but no notable differences in FVC changes during the 12 months of treatment.
  • Overall, both groups did not exhibit significant differences in disease progression or transplant-free survival rates after treatment, suggesting limited benefits of adding immunosuppressants to prednisolone in this context.
View Article and Find Full Text PDF

Background: The latest guidelines on hypersensitivity pneumonitis (HP) categorise the disease as either fibrotic or non-fibrotic because of the greater clinical utility of this stratification. However, the prevalence and incidence of fibrotic and non-fibrotic HP are unknown. This study assessed the exact prevalence and incidence of fibrotic and non-fibrotic HP in Japan in 2021.

View Article and Find Full Text PDF

We evaluated the diagnostic performance of Rapiim SARS-CoV-2-H (Rapiim-H)-a point-of-care qualitative antigen test-using nasopharyngeal swabs (NPS) and saliva samples and compared its results with those from antigen quantification and nucleic acid amplification tests. NPS and saliva were collected from patients with confirmed and suspected coronavirus disease (COVID-19). In total, 142 NPS and saliva samples were collected.

View Article and Find Full Text PDF

A 54-year-old woman with fever and cough presented with left upper lobe consolidation and para-aortic and hilar lymphadenopathies and was diagnosed with sarcoidosis, and her condition improved spontaneously. Over the next 15 years, the patient experienced seven similar episodes and was treated with glucocorticoids for the first time in the eighth episode, but subsequently died of respiratory failure. The autopsy revealed diffuse alveolar damage and co-infection with and Mucorales in the lungs and mediastinum.

View Article and Find Full Text PDF

Background: Visual evaluation of interstitial lung disease (ILD)-related changes can generate intra- and inter-observer errors. However, recent deep learning (DL) algorithm advances have facilitated accurate lung segmentation, lesion characterization, and quantification.

Purpose: To evaluate the treatment response and long-term course in ILD associated with anti-aminoacyl-tRNA synthetase syndrome (anti-ARS ILD) using a DL algorithm.

View Article and Find Full Text PDF

Background: Previous reports indicated still low implementation rates of multigene testing for advanced non-small cell lung cancer (NSCLC) in Japan.

Methods: This is a retrospective study launched at the initiative of lung cancer patients. Patients with stage IV NSCLC from January 2019 to December 2022 were investigated for testing of 8 actionable oncogenic drivers with targeted therapies available as of 2022.

View Article and Find Full Text PDF
Article Synopsis
  • The study explores the effectiveness of multidisciplinary discussions (MDD) among medical professionals for diagnosing interstitial lung diseases (ILDs) and aims to improve diagnostic accuracy, especially for idiopathic pulmonary fibrosis (IPF).
  • It utilizes a nationwide ILD registry in Japan to facilitate rapid MDD diagnoses and develop a modified diagnostic ontology, addressing issues of unclassifiable ILDs and potential new disease entities.
  • The research focuses on providing accurate diagnoses and treatment recommendations, evaluating ILD prevalence, and clarifying reasons for diagnostic challenges through a central online platform for expert collaboration.
View Article and Find Full Text PDF
Article Synopsis
  • Idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) are severe lung diseases that require new treatments, prompting a study on the oral drug admilparant (BMS-986278).
  • A phase 2, randomized, double-blind trial was conducted with 278 IPF patients and 125 PPF patients, who received either 30mg or 60mg of admilparant or a placebo twice daily for 26 weeks, all while allowing background treatments.
  • Results showed that the 60mg dose of admilparant significantly slowed the decline in lung function compared to placebo for both IPF and PPF, with a favorable safety profile, supporting further research in phase 3
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the relationship between Mycobacterium avium complex pulmonary disease (MAC-PD) and interstitial lung disease (ILD), highlighting characteristics specific to patients diagnosed with both conditions.
  • Analysis was conducted on 54 patients with ILD and MAC-PD, revealing that these patients were generally older and had a lower BMI compared to a larger group of ILD patients.
  • The findings indicate that MAC-PD in the context of ILD is associated with a higher rate of complications like chronic pulmonary aspergillosis and a poorer prognosis, especially in those with an unclassifiable imaging type.
View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to assess how common lung cancer is among patients with rheumatoid arthritis (RA) and identify factors that predict its occurrence.
  • - Out of 771 RA patients followed for an average of 9.3 years, different lung conditions showed varied lung cancer incidence rates, with CPFE patients at the highest risk (47.8 cases per 1,000 patient-years).
  • - Findings suggest that RA patients with smoking history and pulmonary complications, particularly CPFE, should be closely monitored for lung cancer risk.
View Article and Find Full Text PDF
Article Synopsis
  • The INCREASE trial demonstrated that inhaled treprostinil enhances exercise capacity in patients with pulmonary hypertension linked to interstitial lung disease (PH-ILD), but lacked specific hemodynamic and pharmacokinetic data.
  • A new trial in Japan evaluated the drug's effects on hemodynamics, exercise capacity, safety, and pharmacokinetics, administering inhaled treprostinil at escalating doses.
  • Results showed a significant reduction in pulmonary vascular resistance and an increase in walking distance over 16 weeks, along with manageable side effects like cough and low blood pressure, indicating the drug's efficacy and safety in this patient group.
View Article and Find Full Text PDF

Monitoring the Efficacy of Tafamidis in ATTR Cardiac Amyloidosis by MRI-ECV: A Systematic Review and Meta-Analysis.

Tomography

August 2024

Department of Diagnostic Radiology, Graduate School of Medicine, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, Yokohama 236-0004, Kanagawa, Japan.

Background: The usefulness of monitoring treatment effect of tafamidis using magnetic resonance imaging (MRI) extracellular volume fraction (ECV) has been reported.

Objective: we conducted a meta-analysis to evaluate the usefulness of this method.

Methods: Data from 246 ATTR-CMs from six studies were extracted and included in the analysis.

View Article and Find Full Text PDF

Background: The benefit of prehospital 12‑lead electrocardiogram (PH-ECG) performed by emergency medical service personnel at the site of first medical contact (FMC) in patients with ST-segment elevation myocardial infarction (STEMI) with cardiogenic shock (CS-STEMI) remains unclear. This study aimed to investigate the effect of PH-ECG on door-to-device time in patients with CS-STEMI.

Methods: This study enrolled CS-STEMI (Killip class IV) patients who were transferred directly to hospitals by ambulance (n = 517) from the Kanagawa Acute Cardiovascular Registry database.

View Article and Find Full Text PDF

Background: Monitoring the progression of idiopathic pulmonary fibrosis (IPF) using CT primarily focuses on assessing the extent of fibrotic lesions, without considering the distortion of lung architecture.

Objectives: To evaluate three-dimensional average displacement (3D-AD) quantification of lung structures using deformable registration of serial CT images as a parameter of local lung architectural distortion and predictor of IPF prognosis.

Materials And Methods: Patients with IPF evaluated between January 2016 and March 2017 who had undergone CT at least twice were retrospectively included ( = 114).

View Article and Find Full Text PDF

The frequency of cardiac amyloidosis potentially present in patients with atrial fibrillation (AF) remains unclear. The purpose of this study is to determine the frequency and clinical characteristics of cardiac amyloidosis latent in AF by performing cardiac magnetic resonance imaging (MRI) in patients scheduled for AF ablation. We retrospectively analyzed 193 consecutive patients who underwent CA and cardiac MRI for atrial fibrillation.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on predicting the prognosis of stage IV lung cancer patients using machine learning algorithms that can be generalized across multiple institutions.
  • It involved a large cohort of over 6,700 patients and assessed the algorithms' performance based on survival predictions over various time frames.
  • The results indicate a high accuracy of the algorithms, with areas under the curve ranging from 0.83 to 0.90 for different survival days, demonstrating potential for broader clinical application.
View Article and Find Full Text PDF

Nonfibrotic (cellular) hypersensitivity pneumonitis with and without slight lung distortion.

Respir Investig

September 2024

Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomioka-higashi, Kanazawa-ku, Yokohama, Kanagawa, 236-0051, Japan.

Background: According to international diagnostic guidelines for hypersensitivity pneumonitis (HP), cases with both nonfibrotic and fibrotic lesions are classified by the predominant feature. Therefore, some cases with nonfibrotic HP, have inflammatory lesions alone, while others have a mixture of fibrosis and inflammation. We investigated the impact of slight fibrotic lesions in nonfibrotic HP.

View Article and Find Full Text PDF